Targacept

Cash-rich Targacept looks beyond Tobacco Road

Celgene’s record-breaking deal hangs on phase II data

December 18, 2013

Despite Targacept and other setbacks, Alzheimer’s remains hot

July 23, 2013

In licensing, you don’t always get what you pay for

November 30, 2012

Big beasts exert influence as biotech comes back from the dead

September 18, 2012

Has off-target Targacept reached the end of the road?

July 19, 2012

Event – Glaxo endorsement puts focus on Amicus phase III result and more

March 20, 2012

Therapeutic focus - Hopes fading for nicotinic receptors as Astra pill flunks

February 29, 2012

Abbott-Galapagos deal ranks amongst largest for phase II asset

January 23, 2012

Key data read outs and patent hearings in the first half of 2012

January 19, 2012

Big pharma's key events for the next six months

Load More